Studies on the Spin State of 3-Methylcholanthrene Induced Cytochrome P-450 from Rat Liver

  • J. O. Stern
  • E. Peisach
  • J. Peisach
  • W. E. Blumberg
  • A. Y. H. Lu
  • S. West
  • D. Ryan
  • W. Levin
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 58)

Summary

The time course of induction of rat liver microsomal cytochrome P-450 by the polycyclic hydrocarbon 3-methylcholanthrene was followed by measuring the specific content of cytochrome P-450, benzpyrene hydroxylase activity, and the percent of cytochrome P-450 existing as the high-spin form (g = 7.9, 3.7 and 1.7) as determined by low temperature EPR spectroscopy. Significant increases in benzpyrene hydroxylase, cytochrome P-450 and high-spin ferric hemoprotein are seen twenty-four hours following 3-methylcholanthrene treatment. Administration of DL-ethionine prior to 3-methylcholanthrene treatment effectively blocks any increase in benzpyrene hydroxylase and cytochrome P-450 but not the increase in the levels of the high-spin species of the hemoprotein normally seen following 3-methylcholanthrene induction. In addition, partially purified cytochrome P-450 can be isolated from liver microsomes of 3-methylcholanthrene treated rats as a low-spin ferric hemoprotein containing essentially no high-spin species (<1%). This partially purified hemoprotein has the same substrate specificity as the microsomes from which it was derived. It is therefore concluded that the appearance of the high-spin form of cytochrome P-450, as quantitated by EPR, does not correlate with the induction of cytochrome P-450 and benzpyrene hydroxylase activity by 3-methylcholanthrene.

Keywords

Polycyclic Hydrocarbon Microsomal Pellet Public Health Service Research Total Cytochrome Liver Microsomal Cytochrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alvares, A. P., Schilling, G. R., Levin, W. and Kuntzman, R. (1967) Biochem. Biophys. Res. Commun. 29, 521.PubMedCrossRefGoogle Scholar
  2. Alvares, A. P., Schilling, G. R. and Kuntzman, R. (1968a). Biochem. Biophys. Res. Commun. 30, 588.PubMedCrossRefGoogle Scholar
  3. Alvares, A. P., Schilling, G. R., Levin, W. and Kuntzman, R. (1968b). J. Pharmacol. Exp. Ther. 163, 417.PubMedGoogle Scholar
  4. Alvares, A. P., Schilling, G. R., Levin, W. and Kuntzman, R. (1971). J. Pharmacol. Exp, Ther. 176, 1.Google Scholar
  5. Berzofsky, J. A., Peisach, J. and Blumberg, W. E. (1971). J. Biol. Chem. 246, 3367.PubMedGoogle Scholar
  6. Comai, K. and Gaylor, J. L. (1973). J. Biol. Chem. 248, 4947.PubMedGoogle Scholar
  7. Conney, A. H., Gillette, J. R., Inscoe, J. K., Trams, E. R. and Posner, H. S. (1959). Science 130, 1478.PubMedCrossRefGoogle Scholar
  8. Conney, A. H. (1967). Pharmacol. Rev. 19, 317.PubMedGoogle Scholar
  9. Feher, G. (1957). Bell Syst. Tech. J. 26, 449.Google Scholar
  10. Fujita, P., Shoeman, D. W. and Mannering, G. J. (1973). J. Biol. Chem. 248, 2192.PubMedGoogle Scholar
  11. Gnosspelius, Y., Thor, H. and Orrenius, S. (1969– 1970). Chem. Biol. Inter. 1, 125.CrossRefGoogle Scholar
  12. Goujon, F. M., Nebert, D. W. and Gielen, J. E. (1972). Mol. Pharmacol. 8, 667.PubMedGoogle Scholar
  13. Hildebrandt, A., Remmer, H. and Estabrook, R. W. (1968). Biochem. Biophys. Res. Commun. 30, 607.PubMedCrossRefGoogle Scholar
  14. Imai, Y. and Sato, R. (1966). Biochem. Biophys. Res. Commun. 23, 521.CrossRefGoogle Scholar
  15. Imai, Y. and Siekevitz, P. (1971). Arch. Biochem. Biophys. 144, 143.PubMedCrossRefGoogle Scholar
  16. Jefcoate, C. R. E. and Gaylor, J. L. (1969). Biochemistry 8, 3464.PubMedCrossRefGoogle Scholar
  17. Levin, W., Ryan, D., West, S. and Lu, A. Y. H. (1973). Drug Metab. Disp. 1, 602.Google Scholar
  18. Levin, W., Ryan, D., West, S. and Lu, A. Y. H. (1974). J. Biol. Chem. 249, 1747.PubMedGoogle Scholar
  19. Levine, W. G. and Singer, R. W. (1972). J. Pharmacol. Exp. Ther. 183, 411.PubMedGoogle Scholar
  20. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951). J. Biol. Chem. 193, 265.PubMedGoogle Scholar
  21. Lu, A. Y. H. and Levin, W. (1972). Biochem. Biophys. Res. Commun. 46, 1334.PubMedCrossRefGoogle Scholar
  22. Lu, A. Y. H., Kuntzman, R., West, S., Jacobson, M. and Conney, A. H. (1972). J. Biol. Chem. 247, 1727.PubMedGoogle Scholar
  23. Lu, A. Y. H., Levin, W., West, S., Jacobson, M., Ryan, D., Kuntzman, R. and Conney, A. H. (1973a). J. Biol. Chem. 248, 456.PubMedGoogle Scholar
  24. Lu, A. Y. H., Levin, W., Ryan, D., West, S., Kuntzman, R., Stern, J. O and Peisach, J. (1973b). Fed. Proc. 32, 762.Google Scholar
  25. Miyake Y., Gaylor, J. L. and Mason, H. S. (1968). J. Biol. Chem. 243, 5788.PubMedGoogle Scholar
  26. Murakami, K. and Mason, H. S. (1967). J. Biol. Chem. 242, 1102.PubMedGoogle Scholar
  27. Nebert, D. W. and Gelboin, H. V. (1968). J. Biol. Chem. 243, 6242.PubMedGoogle Scholar
  28. Nebert, D. W. and Kon, H. (1973). J. Biol. Chem. 248, 169.PubMedGoogle Scholar
  29. Nebert, D. W., Robinson, J. R. and Kon, H. (1973a). J. Biol. Chem. 248, 7637.PubMedGoogle Scholar
  30. Nebert, D. W., Considine, N. and Kon, H. (1973b). Drug Metab. Disp.. 1, 231.Google Scholar
  31. Omura, T. and Sato, R. (1964). J. Biol. Chem. 239, 2379.PubMedGoogle Scholar
  32. Peisach, J. and Blumberg, W. E. (1970). Proc. Nat. Acad. Sc. USA. 67, 172.CrossRefGoogle Scholar
  33. Peisach, J., Stem, J. O. and Blumberg, W. E. (1973). Drug Metab. Disp. 1, 45.Google Scholar
  34. Rickert, D. E. and Fouts, J. R. (1970). Biochem. Pharmacol. 19, 381.PubMedCrossRefGoogle Scholar
  35. Schenkman, J. B., Greim, H., Zange, M. and Remmer, H. (1969). Biochim. Biophys. Acta 171, 23.PubMedGoogle Scholar
  36. Sladek, N. E. and Mannering, G. J. (1966). Biochem. Biophys. Res. Commun. 24, 668.PubMedCrossRefGoogle Scholar
  37. Stern, J. O., Peisach, J., Blumberg, W. E., Lu, A. Y. H. and Levin, W. (1973). Arch. Biochem. Biophys. 156, 404.PubMedCrossRefGoogle Scholar
  38. Winer, B. J. (1962) in Statistical Principles in Experimental Design,” McGraw-Hill Book Co., New York, p. 77.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • J. O. Stern
    • 1
    • 2
    • 3
    • 4
  • E. Peisach
    • 1
    • 2
    • 3
    • 4
  • J. Peisach
    • 1
    • 2
    • 3
    • 4
  • W. E. Blumberg
    • 1
    • 2
    • 3
    • 4
  • A. Y. H. Lu
    • 1
    • 2
    • 3
    • 4
  • S. West
    • 1
    • 2
    • 3
    • 4
  • D. Ryan
    • 1
    • 2
    • 3
    • 4
  • W. Levin
    • 1
    • 2
    • 3
    • 4
  1. 1.Departments of Pharmacology and Molecular BiologyAlbert Einstein College of Medicine of Yeshiva UniversityBronxUSA
  2. 2.Institute for Developmental StudiesNew York UniversityNew YorkUSA
  3. 3.Bell Laboratories, Inc.Murray HillUSA
  4. 4.Department of Biochemistry and Drug MetabolismHoffman-LaRoche, Inc.NutleyUSA

Personalised recommendations